Halozyme Therapeutics
HALO
#2423
Rank
$5.13 B
Marketcap
$38.89
Share price
-1.72%
Change (1 day)
-18.09%
Change (1 year)

P/S ratio for Halozyme Therapeutics (HALO)

P/S ratio as of September 2023 (TTM): 6.63

According to Halozyme Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.63141. At the end of 2023 the company had a P/S ratio of 6.14.

P/S ratio history for Halozyme Therapeutics from 2005 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20236.14-47.32%
202211.7-8.73%
202112.8-40.81%
202021.674.46%
201912.4-11.3%
201813.953.06%
20179.114.45%
20168.72-46.96%
201516.42.11%
201416.1-48.6%
201331.375.34%
201217.91.63%
201117.6-69.93%
201058.548.53%
200939.4-24.36%
200852.0-64.3%
2007146-74.13%
2006564-33.42%
2005847

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.12-37.93%๐Ÿ‡บ๐Ÿ‡ธ USA
2.39-63.98%๐Ÿ‡บ๐Ÿ‡ธ USA
17.8 167.86%๐Ÿ‡บ๐Ÿ‡ธ USA
2.86-56.85%๐Ÿ‡ซ๐Ÿ‡ท France
1.26-80.93%๐Ÿ‡บ๐Ÿ‡ธ USA
6.81 2.63%๐Ÿ‡บ๐Ÿ‡ธ USA